Generalized anxiety disorder (GAD) is a relatively common presentation in primary care and
a significant vulnerability factor for future morbidity, particularly depression and alcohol …

Objective: Generalized anxiety disorder (GAD) is common, chronic, and debilitating.
Treatment with benzodiazepines and newer antidepressants is often inadequate. This article …

The past 10 years have seen a range of safe and effective treatments for GAD. Late-onset
GAD presents a new challenge to researchers and practitioners. The current state of …

Less than one third of people afflicted with generalized anxiety disorder (GAD) experience
spontaneous remission, and the symptoms of GAD wax and wane throughout a person's life …

Generalized anxiety disorder (GAD) is characterized by chronic worry that may persist for
many years. It is a debilitating disorder, and effective long-term treatment is required …

Generalized anxiety disorder (GAD) is a chronic disorder that frequently co-occurs with a
variety of co-morbidities in patients with somatic conditions and other mental disorders. GAD …

Many patients with generalized anxiety disorder (GAD) do not receive adequate treatment.
Several classes of drugs, including benzodiazepines, azapirones, selective serotonin …

Clinical and epidemiological data suggest that generalized anxiety disorder (GAD) is a
chronic illness causing patients to suffer for many years leading to significant distress in …

Selection of appropriate treatment for generalized anxiety disorder (GAD) is influenced by
several considerations, including psychiatric comorbidity. Emerging data suggest that GAD …

Generalized anxiety disorder (GAD) is common anxiety disorder with a lifetime prevalence
rate estimated as 3% 58 to 5%. 4 Unfortunately, although GAD is prevalent and is …